Japan's 1st Drug for ADHD Recommended for Approval

At a meeting on August 29, the CDFS's First Committee on Drugs recommended approval of Japan's first drug for attention deficit/hyperactivity disorders (ADHD) Concerta (methylphenidate HCl) from Janssen Pharmaceutical. This product will be reported to the Department on Drugs scheduled...read more